Semaglutide can be used by people with hypothyroidism, provided thyroid hormone levels are adequately controlled with medication
[45] investigated 46 to 55-year-old participants), uneven distribution of males to females (with many studies predominantly recruiting males [40, 42,43,44,45,46,47, 51]), all of which are factors that may have contributed to variations in study outcomes
Longitudinal studies combining dietary interventions with microbiome sequencing and metabolomic profiling could illuminate causal links
As mentioned earlier, the most important effect of incretins is to stimulate the production and secretion of insulin by the pancreas, and clinical studies show that the activation of this process, whether by stimulation of GLP-1 by semaglutide alone or simultaneous stimulation of GLP-1/GIP by tirzepatide, is associated with better glycemic control in type 2 diabetics